| RS1603256095 |
TBX4
|
Health Risk |
Likely pathogenic |
Pulmonary arterial hypertension, Pulmonary hypertension |
| RS1603262410 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603263147 |
CHM
|
Health Risk |
Pathogenic/Likely pathogenic |
Choroideremia, Retinal dystrophy |
| RS1603263376 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603263395 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor IX deficiency disease |
| RS1603263397 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1603263399 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603263401 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor IX deficiency disease |
| RS1603264205 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1603264236 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603264246 |
F9
|
Health Risk |
Pathogenic |
Reduced factor IX activity, Reduced factor IX activity |
| RS1603264299 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603264300 |
F9
|
Health Risk |
Pathogenic |
Abnormality of coagulation, Abnormality of coagulation |
| RS1603264410 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603264449 |
CHM
|
Health Risk |
Pathogenic |
Choroideremia, Choroideremia |
| RS1603264641 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603264659 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603264705 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603264719 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603264727 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1603264731 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603265480 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603265481 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor IX deficiency disease |
| RS1603265487 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603265493 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603265500 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603265504 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1603265507 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Thrombophilia |
| RS1603265760 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1603265779 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603265827 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603265830 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603265832 |
F9
|
Health Risk |
Pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603266754 |
PHKA1
|
Health Risk |
Pathogenic |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS1603267163 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1603267171 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603267181 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1603267194 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor IX deficiency disease |
| RS1603267332 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603267344 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1603267362 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Warfarin sensitivity |
| RS1603267391 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603267393 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor VIII deficiency disease, Thrombophilia |
| RS1603267398 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603267411 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603267412 |
F9
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary factor IX deficiency disease, Thrombophilia |
| RS1603267420 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603267443 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603267474 |
F9
|
Health Risk |
Likely pathogenic |
Hereditary factor IX deficiency disease, Hereditary factor IX deficiency disease |
| RS1603267486 |
F9
|
Health Risk |
Pathogenic |
— |
| RS1603271580 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked scapuloperoneal muscular dystrophy |
| RS1603271659 |
FHL1
|
Health Risk |
Likely pathogenic |
Myopathy, reducing body |
| RS1603272191 |
FHL1
|
Health Risk |
Pathogenic/Likely pathogenic |
X-linked myopathy with postural muscle atrophy, Familial hemophagocytic lymphohistiocytosis type 1 |
| RS1603272223 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1603272263 |
FHL1
|
Health Risk |
Pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1603273609 |
FHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
X-linked scapuloperoneal muscular dystrophy, X-linked scapuloperoneal muscular dystrophy |
| RS1603273685 |
FHL1
|
Health Risk |
Likely pathogenic |
X-linked myopathy with postural muscle atrophy, X-linked myopathy with postural muscle atrophy |
| RS1603273697 |
FHL1
|
Health Risk |
Pathogenic |
Emery-Dreifuss muscular dystrophy 6, Emery-Dreifuss muscular dystrophy 6 |
| RS1603273984 |
L1CAM
|
Health Risk |
Pathogenic |
L1 syndrome, Ovarian serous cystadenocarcinoma |
| RS1603274308 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS1603274424 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS1603275193 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603275195 |
L1CAM
|
Health Risk |
Pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1603275236 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603275315 |
L1CAM
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1603275338 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603275367 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603275438 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603275538 |
L1CAM
|
Health Risk |
Pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS1603275662 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603275716 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603275723 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603276024 |
L1CAM
|
Health Risk |
Pathogenic |
L1 syndrome, L1 syndrome |
| RS1603276146 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
MASA syndrome, X-linked complicated corpus callosum dysgenesis |
| RS1603276159 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603276180 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603276234 |
L1CAM
|
Health Risk |
Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1603276502 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1603276520 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603276698 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603276728 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603276837 |
BRIP1
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603277005 |
BRIP1
|
Health Risk |
Pathogenic |
Familial cancer of breast, Fanconi anemia complementation group J |
| RS1603277417 |
L1CAM
|
Health Risk |
Pathogenic |
— |
| RS1603277433 |
L1CAM
|
Health Risk |
Likely pathogenic |
X-linked hydrocephalus syndrome, X-linked hydrocephalus syndrome |
| RS1603278993 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603279005 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603279819 |
COL4A5
|
Health Risk |
Pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603280507 |
BRIP1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1603280511 |
DMD
|
Health Risk |
Likely pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603280598 |
DMD
|
Health Risk |
Pathogenic |
— |
| RS1603280621 |
BRIP1
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group J, Familial cancer of breast |
| RS1603280686 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603280745 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Thyroid cancer |
| RS1603280796 |
DMD
|
Health Risk |
Pathogenic |
Duchenne muscular dystrophy, Duchenne muscular dystrophy |
| RS1603282111 |
AVPR2
|
Health Risk |
Pathogenic |
— |
| RS1603282307 |
TCF4
|
Health Risk |
Likely pathogenic |
Pitt-Hopkins syndrome, Pitt-Hopkins syndrome |
| RS1603282342 |
AVPR2
|
Health Risk |
Likely pathogenic |
Diabetes insipidus, nephrogenic |
| RS1603282474 |
COL4A5
|
Health Risk |
Likely pathogenic |
X-linked Alport syndrome, X-linked Alport syndrome |
| RS1603283547 |
COL4A5
|
Health Risk |
Pathogenic |
— |